Terms: = Germ cell tumor AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
24 results:
1. machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
[TBL] [Abstract] [Full Text] [Related]
2. A Competing Risk Model Nomogram to Predict the Long-Term prognosis of Lung Carcinoid.
Wang T; Zhou J; Zheng Q; Wu D; Lu T; Lin M; Pu Q; Mei J; Liu L
Ann Surg Oncol; 2023 Sep; 30(9):5830-5839. PubMed ID: 36917336
[TBL] [Abstract] [Full Text] [Related]
3. Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma.
Wan S; Moure UAE; Liu R; Liu C; Wang K; Deng L; Liang P; Cui H
Front Immunol; 2022; 13():1013094. PubMed ID: 36466844
[TBL] [Abstract] [Full Text] [Related]
4. CD44v6 expression in gastroenteropancreatic neuroendocrine neoplasms: Clinicopathological correlation and prognosis.
Nibhondhratana P; Watcharadetwittaya S; Sa-Ngiamwibool P
Pathol Res Pract; 2022 Dec; 240():154213. PubMed ID: 36403312
[TBL] [Abstract] [Full Text] [Related]
5. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
6. Integrative analysis reveals the functional implications and clinical relevance of pyroptosis in low-grade glioma.
Shen L; Li Y; Li N; Zhao Y; Zhou Q; Shen L; Li Z
Sci Rep; 2022 Mar; 12(1):4527. PubMed ID: 35296768
[TBL] [Abstract] [Full Text] [Related]
7. Predicting the prognosis of glioma by pyroptosis-related signature.
Chao B; Jiang F; Bai H; Meng P; Wang L; Wang F
J Cell Mol Med; 2022 Jan; 26(1):133-143. PubMed ID: 34816605
[TBL] [Abstract] [Full Text] [Related]
8. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas.
Güvenç C; Antoranz A; Szumera-Ciećkiewicz A; Teterycz PP; Rutkowski PR; Rawson RV; Scolyer RA; Thompson JF; Newton-Bishop J; Stas M; Boecxstaens V; Bechter O; Vercauteren J; Garmyn M; van den Oord J; Bosisio FM
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638912
[TBL] [Abstract] [Full Text] [Related]
9. Establishment and validation of five autophagy-related signatures for predicting survival and immune microenvironment in glioma.
Zhao Z; Wu Y; Wang Z; Xu J; Wang Y; Zhao Z
Genes Genomics; 2022 Jan; 44(1):79-95. PubMed ID: 34609723
[TBL] [Abstract] [Full Text] [Related]
10. Association of RASSF1A, DCR2, and casp8 Methylation with Survival in Neuroblastoma: A Pooled Analysis Using Reconstructed Individual Patient Data.
Hassan WM; Bakry MS; Siepmann T; Illigens B
Biomed Res Int; 2020; 2020():7390473. PubMed ID: 33381579
[TBL] [Abstract] [Full Text] [Related]
11. Whether statin use improves the survival of patients with glioblastoma?: A meta-analysis.
Xie Y; Lu Q; Lenahan C; Yang S; Zhou D; Qi X
Medicine (Baltimore); 2020 Feb; 99(9):e18997. PubMed ID: 32118710
[TBL] [Abstract] [Full Text] [Related]
12. Endoplasmic Reticulum Stress Contributes to Indomethacin-Induced Glioma Apoptosis.
Chang CY; Li JR; Wu CC; Wang JD; Liao SL; Chen WY; Wang WY; Chen CJ
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952288
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis.
Hu G; Wang R; Wei B; Wang L; Yang Q; Kong D; Du C
J Comput Biol; 2020 Jan; 27(1):81-90. PubMed ID: 31433208
[TBL] [Abstract] [Full Text] [Related]
14. Caspase-8: A Novel Target to Overcome Resistance to Chemotherapy in Glioblastoma.
Fianco G; Contadini C; Ferri A; Cirotti C; Stagni V; Barilà D
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501030
[TBL] [Abstract] [Full Text] [Related]
15. Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases.
Bentivegna E; Azaïs H; Uzan C; Leary A; Pautier P; Gonthier C; Genestie C; Balleyguier C; Lhomme C; Duvillard P; Morice P; Gouy S
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S964-70. PubMed ID: 26033179
[TBL] [Abstract] [Full Text] [Related]
16. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives.
Buder K; Gesierich A; Gelbrich G; Goebeler M
Cancer Med; 2013 Oct; 2(5):674-86. PubMed ID: 24403233
[TBL] [Abstract] [Full Text] [Related]
17. Methylation-specific multiplex ligation-dependent probe amplification and its impact on clinical findings in medulloblastoma.
Feierabend D; Walter J; Grube S; Herbold C; Beetz C; Kalff R; Ewald C
J Neurooncol; 2014 Jan; 116(2):213-20. PubMed ID: 24162828
[TBL] [Abstract] [Full Text] [Related]
18. Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomas.
Asada K; Watanabe N; Nakamura Y; Ohira M; Westermann F; Schwab M; Nakagawara A; Ushijima T
Jpn J Clin Oncol; 2013 Jun; 43(6):641-5. PubMed ID: 23619990
[TBL] [Abstract] [Full Text] [Related]
19. The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.
Haug AR; Cindea-Drimus R; Auernhammer CJ; Reincke M; Wängler B; Uebleis C; Schmidt GP; Göke B; Bartenstein P; Hacker M
J Nucl Med; 2012 Nov; 53(11):1686-92. PubMed ID: 22984220
[TBL] [Abstract] [Full Text] [Related]
20. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
[TBL] [Abstract] [Full Text] [Related]
[Next]
